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Abstract
Background/Aim: Lipoprotein lipase (LPL) is the main
enzyme responsible for the distribution of circulating
triacylglycerides in tissues. Its regulation via release
from active sites in the vascular endothelium is poorly
understood. In a previous study we reported that in
response to acute immobilization (IMMO), LPL activity
rapidly increases in plasma and decreases in white
adipose tissue (WAT) in rats. In other stress situations
IMMO triggers a generalized increase in nitric oxide
(NO) production. Methods/Results: Here we
demonstrate that in rats: 1) in vivo acute IMMO rapidly
increases NO concentrations in plasma 2) during
acute IMMO the WAT probably produces NO via the
endothelial isoform of nitric oxide synthase (eNOS)
from vessels, and 3) epididymal WAT perfused in situ
with an NO donor rapidly releases LPL from the
endothelium. Conclusion: We propose the following
chain of events: stress stimulus / rapid increase of
NO production in WAT (by eNOS) / release of LPL
from the endothelium in WAT vessels. This chain of
events could be a new mechanism that promotes the
rapid decrease of WAT LPL activity in response to a
physiological stimulus.
Introduction
Lipoprotein lipase (LPL, EC 3.1.1.34) is a
homodimeric glycoprotein enzyme that hydrolyzes
triacylglycerols (TAG) from plasma lipoproteins, thereby
releasing non-esterified fatty acids for tissue uptake and
metabolization. LPL is synthesized by parenchymal cells,
from which it is secreted and then transported, by a poorly
understood process, to the lumen surface of endothelial
cells. The physiologically-active form of LPL is localized
on the surface of the vascular endothelium of the tissues
in which it is synthesized, where it is anchored by a
membrane-bound glycosaminoglycan chain (heparan and
dermatan sulphate) [1]. After a short half-life (about one
hour) [2, 3], the enzyme is released from its anchorage in
a monomeric, inactive form and travels through the blood
to the liver, where it is captured [4] and degraded.
LPL regulation is limited and determined by its
extracellular localization. It is regulated in the medium-
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term depending on the rate of its synthesis [5, 6]. In
addition, LPL activity can also be regulated by its release
from the endothelium, which transiently increases plasma
enzyme activity. Although little is known about this,
increased LPL activity levels in plasma have been
described in several physiological conditions including
fasting [7] and some types of exercise [8]. Moreover,
the repeated injection of epinephrine and the β-adrenergic
agonist isoproterenol in rats causes a decrease in LPL
activity in WAT but an increase in plasma [9]. Similarly,
in previous research we showed that after acute
immobilization (IMMO) in rats, LPL activity decreases
in retroperitoneal WAT depots and rises in plasma [10].
In recent studies these changes were observed within
only 5 minutes of IMMO [11].
In rats, IMMO stress triggers a generalized increase
in nitric oxide (NO) production [12], and induces iNOS
expression and NO overproduction in the brain cortex
[13]. NO is synthesized by a family of three isoenzymes:
the constitutive neuronal (nNOS or NOS I), the endothelial
(eNOS or NOS III), and the inducible (iNOS or NOS II)
nitric oxide synthases (NOS). These isotypes have distinct
tissue localization, eNOS being the main isoenzyme in
endothelial cells, where it is involved in vasodilatation.
NO is the main local modulator of blood flow [14].
Furthermore, NO, through its derivatives, called reactive
nitrogen species, reacts with the thiol group of cysteine
and the phenol ring of tyrosine (tyrosine nitration) of
proteins, thereby modifying their biological activities [15-
18].
Several authors have proposed a link between NO
production and LPL down-regulation. In brown adipocytes,
TNFα induces NO production by iNOS, whereas LPL
activity decreases [19]. Lipopolysaccharide administration
in rats in vivo induces iNOS expression in muscle and
WAT, and increases nitrate/nitrite levels in plasma while
decreasing LPL activity in both tissues [20].
To examine the possible role of NO in the short-
term regulation of WAT LPL activity, here we used a) an
in vivo acute stress model by IMMO and b) in situ
perfusion of eWAT with an NO donor.
Materials and Methods
Stress by IMMO
A) Animals. Male Wistar rats (Harlan Interfauna Ibèrica,
Barcelona, Spain) weighing 190-240 g were housed in a
controlled noise-free environment (lights on from 8 am to 8 pm,
temperature 23 ± 2°C, humidity 45-55%). The rats had access to
a standard laboratory diet (Panlab, Barcelona, Spain) and water
ad libitum. All procedures involving animals were approved
by the Committee on Animal Bioethics and Care at the
University of Barcelona and the Government of Catalonia
(Spain).
B) Immobilization stress (IMMO). The body
immobilization procedure was based on that described by
Kvetnansky and Mikulaj [21] and used elsewhere [11, 22]. Rats
were attached to wooden boards in prone position by taping
their forelimbs and hind limbs to metal mounts. To restrict head
movement, the head was placed inside a plastic tube and fixed
over the neck area.
C) Experimental groups. The experimental groups used
were as described in a previous study [11]. Briefly, rats were
randomly assigned to one of four groups: control or non-stress
(0 minutes of IMMO, time 0) and 5, 15, or 25 min of IMMO
(times 5, 15 and 25). Experiments of stress were always done
between 2:00 and 4:00 PM [10, 11, 22] to minimize the effects of
circadian rhythms and the diet on the parameters studied. Rats
were subjected to IMMO for 0, 5, 15 and 25 minutes and
decapitated immediately thereafter. Blood was collected in
EDTA and white adipose tissues (epididymal and
retroperitoneal, eWAT and rWAT respectively) were removed
and immediately frozen in liquid nitrogen. Plasmas and WAT
were used for LPL activity quantification (published before,
see reference 11). Plasma was obtained in EDTA from blood to
measure nitrates to avoid interferences that other anticoagulants
might cause with plasma nitrate determination [23]. In another
set of animals, decapitated after 30 minutes of IMMO,
epididymal and retroperitoneal WAT (eWAT and rWAT) were
removed and used for histological NO detection and Western
blot analysis of NOS synthases (eNOS and iNOS).
D) Plasma nitrate determination. We used the Griess
assay with modifications adapted to plasma samples [23]. Briefly,
samples were incubated with nitrate reductase (Cayman-
Chemical, Ann Arbor, MI, USA) to reduce nitrate to nitrite. The
Griess reagent (sulfanilamide 2% (w/v) and N-(1-naphthyl)
ethylenediamine 0.2% (w/v) (1:1) (v/v)) was then added and
absorbance was measured at 540 nm (Titertek Multiskan PLUS
MKII).
E) eNOS and iNOS detection by Western blot in WAT.
Tissues were homogenized (200 mg/mL) in a 50 mM Tris buffer,
pH 7.4, containing 0.1 mM EDTA, 0.1 mM EGTA, 1% (v/v)
Triton X-100, 1 mM β-mercaptoethanol and 2 mM Pefabloc
RSC and Complet Mini as protease inhibitors (both from Roche
Diagnostics). Homogenates (170 µg of protein) and positive
control were loaded onto an 8% (w/v) polyacrylamide gel and
transferred to a PVDF membrane, followed by blocking in Tris-
buffered saline (TBS) containing 5% (w/v) non-fat dry milk
(blocking buffer). For iNOS detection, incubation with a rabbit
anti-rat iNOS antibody (Santa Cruz Biotechnology,  Santa Cruz,
CA, USA) 1:500 (v/v) was carried out in blocking buffer
overnight at 4°C. The same buffer was used in a Western blot
for eNOS detection with a mouse anti-human eNOS monoclonal
antibody (Transduction Laboratories, Lexington, KY, USA)
1:10,000 (v/v). The extent of the expression of eNOS activated
(via the residue Ser1177) in WAT by specific antibodies was
not measured due to the large amount of protein that is needed
to detect it by Western blot.
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A goat horseradish peroxidase-labeled anti-mouse IgG
(Chemicon, Temecula, CA, USA) and a swine horseradish
peroxidase-labeled anti-rabbit IgG (Dako, Glostrup, Denmark)
were used 1:10,000 (v/v) for eNOS and iNOS immunoblotting
detection respectively, using the SuperSignal West Pico
Chemiluminescent Substrate system (PIERCE, Rockford, IL.
USA).
F) NO production in histological sections from eWAT.
Fresh tissue fragments were fixed for 2 h at 4ºC in 0.1 M PBS,
pH 7.4, containing 4 % (w/v) paraformaldehyde. Tissue sections
(18 µm-thick) obtained by cryostat were incubated with a mixture
of L-arginine 100 μM and 10 μM 4,5-diaminofluorescein
diacetate (DAF-2 DA, Calbiochem, Darmstadt, Germany)
diluted in PBS for 1.5 h at 37°C as previously described [24].
Incubations were performed in the absence or presence of
EDTA (a chelator of Ca2+) to test the active eNOS (specific
calcium required). Tissue sections maintained the vessel
structure but not the adipocyte integrity. NO production by
eNOS of vessels in the tissue sections was examined under a
fluorescence microscope (Nikon Eclipse E600), using λ
excitation at 495 nm and λ emission at 515 nm. Images were
obtained using Ultraview Imaging Suite software (Perkin Elmer
Life Sciences). Data were obtained only in eWAT because this
methodology could not be applied to rWAT due to the low
number of vessels and their small diameter.
Perfusion of eWAT
The technique used is described in our previous study
[25]. Briefly, the method entails perfusion of the right epididymal
fat pad, from the aorta and spermatic artery to the spermatic
vein and cava. LPL activity measured in the perfused right fat
pad is similar to that measured in the non-perfused left fat pad,
and the perfused tissue is viable and metabolically active [25].
eWAT was perfused for 10 minutes with a medium
(Minimum Essential Medium (MEM, Gibco, Carlsbad, CA, USA)
containing 3% (w/v) BSA, 20 mM citrate and 1 nM insulin).
After that, spermine-NONOate (Calbiochem, Darmstadt,
Germany) or spermine (Sigma, St. Louis, MO, USA), the NO-
carrying molecule (control group), was added to the medium
(100 µM) at time 0. Spermine-NONOate is an NO donor selected
on the basis of its stability in the same buffer used for perfusion
[26]. The perfusate was collected at 5 minute intervals (until 30
minutes) in Eppendorf tubes kept in iced water, and immediately
stored at -80ºC. In other sets of animals, perfusion was stopped
at 5 and 30 minutes after the addition of spermine or spermine
NONOate and the tissue was collected and frozen in liquid
nitrogen.
LPL activity assay
Tissues were homogenized (≈ 200 mg) in 1 mL of buffer
(10 mM HEPES, 1 mM EDTA, 1 mM DTT, 5 U/mL heparin, pH
7.5). LPL activity was determined in homogenates, plasmas
and perfusates as previously described [9, 27]. Production of
1µmoL oleate per minute (from tri[9,10(n)-3H]oleate) is
equivalent to 1 U LPL.
Statistic analysis
Results are given as the means ± SEM. Data obtained in
experiment of IMMO were statistically analyzed by one-way
ANOVA (time of stress), and data obtained in experiment of
perfusion, by two-way ANOVA (time and treatment, repeated-
measures). A post hoc Tukey test was used. Differences were
considered significant when P < 0.05.
Results and Discussion
Stress by IMMO
Acute stress by IMMO significantly increased (four-
fold) nitrate levels (an index of NO production, [28]) at
15 minutes (Figure 1). After 25 minutes, levels had
decreased to near baseline. This increase in NO
production in response to IMMO is consistent with
previous reports using the same stress model in rats [12].
Moreover in response to acute IMMO we found that
LPL activity rose in plasma and decreased in rWAT, all
after 5 minutes of IMMO [Table 1, summary of results
obtained in the same animals and previously published,
see reference 11]. The fact that NO3- increased in plasma
later (at 15 minutes) than LPL (at 5 minutes) does not
contradict our hypothesis that NO causes LPL release
because the rate of basal production of NO in vivo [29]
could explain the delay in nitrate accumulation in plasma.
Given that NO is a major local flow regulator [14]
and we found that blood flow increases specifically in
WAT after acute IMMO stress [10], NO synthesis by
NOS in WAT could be partly responsible for the in vivo
NO production observed in this study, although other
tissues could be involved in its production. The NOS
activity that caused this production must correspond to
eNOS because: 1) in non-stressed rats it was the main
isoenzyme in WAT (Figure 2); 2) although
lipopolysaccharide administration in rats induces iNOS
expression in WAT [18, 30] and chronic IMMO induces
iNOS in brain cortex [13], iNOS was not expressed in
WAT after 30 minutes of acute IMMO (Figure 2); and 3)
NOS activity detected using a histochemical procedure
(DAF) was blocked by EDTA, a chelator of calcium
required for eNOS but not for iNOS activity ([31], Figure
3), or by the NOS inhibitor L-NAME, (D. Ricart,
unpublished data). Furthermore: shear stress (enhanced
in WAT by IMMO because of increased blood flow, [10])
stimulates eNOS activity, thereby increasing NO
production [31-34].
Perfusion of eWAT
The effect of an NO donor on LPL bound to the
capillary endothelium was studied in eWAT perfused
in situ (Figure 4).
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Since NONOate cross-reacts with the Griess
reagent (N. Jané, unpuplished data), we were unable to
measure the nitrite concentration in the perfusates. We
thus chose a spermine NONOate dose of 100µM that,
when prepared in a culture buffer, produces NO at a rate
of 2-4 µM/minute on the basis of data taken from the
literature [26]. Moreover, 100 µM lies within the low range
of the concentrations used for assays in vitro [35].
The addition of spermine-NONOate (NO donor)
resulted in a rapid (5 minutes) and significant increase in
LPL activity in the perfusate (Figure 4, panel A), thereby
demonstrating the release of LPL from its endothelial
location. In accordance with this result, tissue LPL activity
tended to decrease (although non-significantly) 5 minutes
after the addition of this NO donor (Figure 4, panel B)
Fig. 3. Vascular NO production in histological sections from
eWAT. Endothelial NO production in representative
18 μM-thick slices of rat eWAT (30 minutes stressed by IMMO
and non-stressed). Tissue sections were incubated with a
mixture of L-arginine and DAF-2 DA for NO detection, in the
absence (-) or presence (+) of EDTA (a chelator of Ca2+).
eNOS activity was abolished with EDTA incubation.
The DAF-NO complex was observed in a fluorescence
microscope (λ: excitation-emission of 495-515 nm). Thick arrows
indicate diffuse fluorescence corresponding to NO production.
The spiral ring and the external ring (thin arrows) are caused
by autofluorescence of the sample, and correspond to
internal and external elastic layers of the vessels
respectively. Bar = 100 µm.
Fig. 2. eNOS and iNOS expression in WATs. Representative
Western blots of eNOS (140kDa) and iNOS (130kDa) in
epididymal (eWAT) and retroperitoneal (rWAT) white adipose
tissue (170 µg of protein /well) from non-stressed (control,
n= 4) and stressed (30 minutes of IMMO, n=4) rats. Each lane
corresponds to a different animal. Positive controls (+) were
performed at each gel and NOS type. Homogenates and positive
controls were loaded in the same gel.
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Fig. 1. The effect of acute stress by IMMO on nitrate con-
centration in plasma. Data are means ± SEM of 7 rats each time.
Statistical comparisons by one-way ANOVA (time of IMMO)
followed by Tukey tests. *** = P < 0.001 compared with control
or basal situation (0 minutes).
Table 1. LPL activity in plasma, epididymal (eWAT) and
retroperitoneal (rWAT) white adipose tissues during acute
stress by IMMO (summary of results published in Casanovas
et al.[11]). Data are means ± SEM of 6 rats each time. Statistical
comparisons by one-way ANOVA (time of IMMO) followed by
Tukey tests. * = P < 0.05 compared with control or basal
situation (0 minutes).
Cell Physiol Biochem 2008;22:525-530
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Fig. 4.  The effect of NO donor on LPL activity in an in situ
perfused eWAT. Rat eWAT was perfused in situ with 100 µM
spermine-NONOate (NO donor at physiological concentra-
tions, continuous line-panel A and black bar-panel B) or with
100 µM spermine (the carrier molecule, broken line-panel A and
white bar-panel B). In panel A, LPL activity was measured in
the perfusate (mU/mL) at several time points during perfusion.
In panel B the experimental procedure was interrupted at 5
minutes when perfusion began and total LPL activity (mU) was
measured in perfused tissue. Data are mean ± SEM of 4-5 animals
per group. In panel A (perfusate), effect of treatment =
P < 0.001, by ANOVA (repeated-measures). In panel B (tissue)
no significant differences were found between groups, by
Student t-test.
remaining to similar levels 30 minutes after (N. Jané,
unpublished data). These effects must be specific to the
NO produced because they were not observed after the
addition of the NO-carrying molecule, spermine. The dose
of the NO donor used in the perfusion does not interfere
with the assay of LPL activity in WAT homogenates (N.
Jané, unpublished data). Furthermore, the activity found
in the perfusate after NO donor perfusion was lower than
that found after heparin perfusion [25], probably because
heparin has a greater capacity to displace LPL from its
anchorage and it also stabilizes the dimer.
Physiological implications
During physiological stress, such as IMMO,
catecholamines increase blood flow in WAT [10] and
nitrates in plasma (Figure 1). Circulating catecholamines
induce vasodilatation in WAT [36], perhaps increasing NO
production by stimulating one of the protein kinases that
activates eNOS [33]. Mechanical forces related to blood
flow may strengthen and maintain NO production i.e., by
continuous shear stress [31, 33, 34]. In this context, WAT
switches from being an importer to an exporter of fatty
acids. This switch results in increased blood flow, which
may enable this tissue to rapidly export free fatty acids
for energy requirements in other tissues (i.e. heart and
muscle) [10, 11]. LPL activity then decreases rapidly in
WAT (Table 1, [11]) and reduces the uptake of circulating
lipids [10, 22]. The speed of this reduction is inexplicable
by the known mechanisms of LPL regulation. Thus, the
LPL release from the endothelium to the bloodstream
was proposed as a fast mechanism for the down-
regulation of tissue LPL activity [11].
Although several studies in adipose tissue suggest
the mediation of NO production and NOS activity in LPL
regulation [19, 20], our results using an in situ perfusion
WAT model provide the first evidence of a cause-effect
relationship between NO production and LPL release.
Given the luminal co-localization of functional LPL and
eNOS in the endothelium, the local NO and/or some NO
derivatives could immediately act on LPL, thereby
favoring its release into plasma and decreasing its activity
in WAT. However, further studies are required to gain
insight into LPL and NO interaction.
The proposed effect of NO releasing functional LPL
from adipose tissue could be included in a more general
role of NO modulation of energy metabolism in
physiological and pathological conditions [30].
Abbreviations
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